Immunovant reported net income of -$153.22M for the quarter ended Jun 2026. This income statement covers 31 quarters of results from Dec 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 115.00M | 115.11M | 116.48M | 116.52M | 116.61M | 129.26M | 130.33M | 130.57M | 131.44M | 145.09M | 145.58M | 146.20M | 146.57M | 147.20M | 170.11M | 171.07M | 174.53M | 203.32M | 203.94M | 206.26M | |||||||||||
| Operating items | |||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 21.36M | 29.76M | 31.99M | 28.43M | 37.74M | 42.25M | 51.84M | 50.58M | 47.96M | 48.34M | 66.06M | 75.47M | 97.27M | 94.52M | 93.65M | 101.20M | 114.25M | 98.92M | 142.29M | 142.63M | |||||||||||
| Selling, General & AdministrativeSG&A | 16.29M | 11.52M | 15.24M | 11.95M | 11.88M | 11.78M | 12.42M | 15.40M | 13.84M | 13.21M | 14.82M | 18.81M | 18.47M | 19.78M | 20.17M | 26.02M | 17.51M | 15.44M | 17.27M | 17.69M | |||||||||||
| Other Operating ExpensesOther Opex | 10.00M | 12.50M | |||||||||||||||||||||||||||||
| Operating ExpensesOpex | 37.65M | 41.27M | 47.23M | 40.38M | 49.61M | 64.03M | 64.26M | 78.48M | 61.80M | 61.55M | 80.88M | 94.28M | 115.74M | 114.30M | 113.83M | 127.22M | 131.76M | 114.36M | 159.55M | 160.32M | |||||||||||
| Operating IncomeOp. Inc | |||||||||||||||||||||||||||||||
| EBIT | -37.73M | -41.38M | -47.18M | -40.02M | -47.67M | -62.84M | -60.42M | -73.95M | -58.21M | -51.53M | -75.09M | -87.07M | -109.04M | -110.97M | -105.87M | -119.70M | -125.91M | -109.08M | -150.70M | -153.22M | |||||||||||
| Non-operating items | |||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | |||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 4.07M | 3.57M | 8.93M | 8.38M | 7.18M | 6.07M | 4.59M | 6.89M | 6.34M | 5.60M | 5.33M | 8.06M | 7.09M | ||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.08M | -0.11M | 0.04M | 0.35M | 0.79M | -1.76M | 0.36M | 0.46M | 0.02M | 1.09M | -2.59M | 0.03M | 0.63M | -1.26M | 1.07M | 1.19M | 0.25M | -0.05M | 0.80M | 0.00M | |||||||||||
| Net income details | |||||||||||||||||||||||||||||||
| EBT | -37.73M | -41.38M | -47.18M | -40.02M | -47.67M | -62.84M | -60.42M | -73.95M | -58.21M | -51.53M | -75.09M | -87.07M | -109.04M | -110.97M | -105.87M | -119.70M | -125.91M | -109.08M | -150.70M | -153.22M | |||||||||||
| Tax ProvisionsTaxes | -0.03M | -0.01M | 0.35M | 0.26M | 0.39M | -0.99M | -0.01M | 0.45M | -0.11M | 0.23M | 0.08M | 0.08M | 0.15M | 0.58M | 0.91M | 0.59M | 1.55M | -2.84M | |||||||||||||
| Profit After TaxPAT | -37.70M | -41.38M | -47.17M | -40.37M | -47.93M | -63.23M | -59.43M | -73.94M | -58.66M | -51.42M | -75.32M | -87.15M | -109.12M | -111.12M | -106.45M | -120.61M | -126.50M | -110.64M | -147.86M | -153.22M | |||||||||||
| Income from Continuing OperationsIncome (Continuing) | -37.70M | -41.38M | -47.17M | -40.37M | -47.93M | -63.23M | -59.43M | -73.94M | -58.66M | -51.42M | -75.32M | -87.15M | -109.12M | -111.12M | -106.45M | -120.61M | -126.50M | -110.64M | -147.86M | -153.22M | |||||||||||
| Consolidated Net IncomeConsol Net Inc. | -37.70M | -41.38M | -47.17M | -40.37M | -47.93M | -63.23M | -59.43M | -73.94M | -58.66M | -51.42M | -75.32M | -87.15M | -109.12M | -111.12M | -106.45M | -120.61M | -126.50M | -110.64M | -147.86M | -153.22M | |||||||||||
| Income towards Parent CompanyParent Net Inc | -37.70M | -41.38M | -47.17M | -40.37M | -47.93M | -63.23M | -59.43M | -73.94M | -58.66M | -51.42M | -75.32M | -87.15M | -109.12M | -111.12M | -106.45M | -120.61M | -126.50M | -110.64M | -147.86M | -153.22M | |||||||||||
| Net Income towards Common StockholdersNet Income | -37.70M | -41.38M | -47.17M | -40.37M | -47.93M | -63.23M | -59.43M | -73.94M | -58.66M | -51.42M | -75.32M | -87.15M | -109.12M | -111.12M | -106.45M | -120.61M | -126.50M | -110.64M | -147.86M | -153.22M | |||||||||||
| Additional items | |||||||||||||||||||||||||||||||
| EPS (Basic) | -0.35 | -0.36 | -0.43 | -0.35 | -0.41 | -0.49 | -0.48 | -0.57 | -0.45 | -0.36 | -0.55 | -0.60 | -0.74 | -0.76 | -0.70 | -0.71 | -0.73 | -0.61 | -0.81 | -0.75 | |||||||||||
| EPS (Diluted) | -0.35 | -0.36 | -0.43 | -0.35 | -0.41 | -0.49 | -0.48 | -0.57 | -0.45 | -0.36 | -0.55 | -0.60 | -0.74 | -0.76 | -0.70 | -0.71 | -0.73 | -0.61 | -0.81 | -0.75 | |||||||||||
| Shares Outstanding | 109.08M | 115.03M | 109.68M | 116.56M | 116.57M | 128.57M | 123.08M | 130.50M | 131.16M | 144.52M | 138.10M | 146.09M | 146.47M | 146.92M | 151.57M | 170.87M | 173.64M | 181.51M | 182.42M | 205.55M | |||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 109.08M | 115.03M | 109.68M | 116.56M | 116.57M | 128.57M | 123.08M | 130.50M | 131.16M | 144.52M | 138.10M | 146.09M | 146.47M | 146.92M | 151.57M | 170.87M | 173.64M | 181.51M | 182.42M | 205.55M | |||||||||||
| EBITDA | -37.73M | -41.38M | -47.18M | -40.02M | -47.67M | -62.84M | -60.42M | -73.95M | -58.21M | -51.53M | -75.09M | -87.07M | -109.04M | -110.97M | -105.87M | -119.70M | -125.91M | -109.08M | -150.70M | -153.22M | |||||||||||
| Interest ExpensesInt Expense | |||||||||||||||||||||||||||||||
| Tax Rate | 0.08 | 0.03 | -0.88 | -0.55 | -0.62 | 1.64 | 0.01 | -0.78 | 0.21 | -0.31 | -0.09 | -0.07 | -0.14 | -0.55 | -0.76 | -0.47 | -1.42 | 1.89 |